Europe
United Kingdom
Europe
United Kingdom

The 'go to' European specialist pharma company

Pipeline

We operate in three core therapy areas – gastroenterology, hepatology, cancer and supportive care.

 

Compound

Mechanism of action

Therapy area

Area under investigation 

Phase

Originator / Partner

NPJ5007

 

Personalised cell based product

Gastroenterology

Faecal incontinence

II

Innovacell

XIFAXAN®

Non-absorbed broad spectrum antibiotic

Gastroenterology

Crohn's Disease

III

Alfa Wassermann

PLENVU®

(NER 1006)

Osmotic laxative

Gastroenterology

Bowel cleansing

III

Norgine B.V.

CAMETOR®/

OBLEAN®

Lipase inhibitor

Gastroenterology

Weight loss / obesity

Registration / Launch

Norgine B.V.

GELSECTAN®

Xyloglucan, vegetal proteins and xylo-oligosaccharides

Gastroenterology

Irritable Bowel Syndrome (IBS) associated with diarrhoea Registration / Launch

Noventure 

 
June 2016. GL/COR/0616/0071